Program for all days

• Banff Transplantation Pathology Update
  AgnesFogo Speaker United States
• Lesions after stem cell transplantation
  SuryaSeshan Speaker United States
• Digital pathology and artificial intelligence applications in kidney transplant pathology
  PeterBoor Speaker Germany

• High level summary of the two previous webinars
  AdeeraLevin Speaker Canada
• Trials Without Borders
  RathikaKrishnasamy Speaker Australia
• Use of novel tools
  Pedro HenriqueFranca Gois Speaker Australia
• Designing Trials for Inclusivity and Generalizability
  Andrea Vichelli Speaker Australia

• AKI due to chemotherapy
  Diana CarolinaVargas Angel Speaker Colombia
• AKI due to targeted therapy
  MotokoYanagita Speaker Japan
• AKI due to immunotherapy
  Maria JoseSoler Speaker Spain
• Roundtable Discussion
  KenarJhaveri Moderator United States

• Introduction to concepts/principles of Kidney Supportive Care and Conservative Kidney Management
  SaraDavison Speaker Canada
• Joint Talk: Planning for conservative kidney management - A Tale of Two Cities
  BarnabyHole Speaker United Kingdom

  PeaceBagasha Speaker Uganda
• Essential communication skills for successful advance care planning

• Welcome
  FergusCaskey Speaker United Kingdom
• Introduction
  ToshihideNaganuma Speaker Japan
• Experiences in establishing a haemodialysis registry in Nepal
  DibyaSingh Shah Speaker Nepal
• Status of dialysis therapy in Mongolia according to nationwide annual dialysis registry
  AdiyaSaruultuvshin Speaker Mongolia
• Application of a national kidney registry to the Japanese clinical practice guidelines
  JunichiHoshino Speaker Japan
• Panel Discussion

• Update on diabetes kidney disease management
  SunitaBavanandan Speaker Malaysia
• New Drugs for Polycystic Kidney Disease
  MichelChonchol Speaker United States
• B cell targeted therapies for glomerular diseases
  RichardLafayette Speaker United States

• CVC Tunneled Catheter Placement and Troubleshooting on Simulator and Healthy Volunteers
  BernardoMoguel González Speaker Mexico

  Hoon SukPark Speaker South Korea
• HD access: Venous mapping, AVF – physical exam, US evaluation for maturity, guide cannulation through simulator
  ToshihideNaganuma Speaker Japan

  VandanaNiyyar Speaker United States
• Volume assessment: Lungs/IVC
  BhavnaBhasin-Chhabra Speaker United States

  EduardoArgaiz Speaker Mexico

• Spectrum of IgG4 related kidney diseases
  TakakoSaeki Speaker Japan
• Spectrum of tropical infections/Renal lesions in parasitic diseases
  AhmedKalebi Speaker Kenya
• Undetermined kidney diseases- a genomic approach towards diagnosis
  LaurentMesnard Speaker France

• Japanese Perspective
  MegumiOshima Speaker Japan
• African Perspective
  RobertKalyesubula Speaker Uganda
• Insights on consent challenges in low and middle-income countries
  ShuchiAnand Speaker United States
• Closing the loop: Returning results to participants: why and how
  AdeeraLevin Speaker Canada

  BillWang Speaker Hong Kong, China

• Hyponatremia in the cancer patient
  SanjeevNair Speaker India
• Hypercalcemia in the cancer patient
  MohamedHassanein Speaker Egypt
• Hypomagnesemia and hypophosphatemia in the cancer patient
  JolantaMalyszko Speaker Poland
• Roundtable discussion
  KenarJhaveri Moderator United States

• Management of restless legs, CKD-associated itch, and insomnia in Conservative Kidney Management
  BrendanSmyth Speaker Australia
• Management of pain in Conservative Kidney Management
  PramoteEuasobhon Speaker Thailand
• Management of fatigue and mental health in Conservative Kidney Management
  PeaceBagasha Speaker Uganda

• Embedding randomisation in a national CKD registry: for the SACK study of apixaban in atrial fibrillation
  MarieEvans Speaker Sweden
• Platform trials utilising routine data for paediatric rare diseases
  DorotheaNitsch Speaker United Kingdom
• Lessons learned from conducting haemodialysis and peritoneal dialysis trials in ANZDATA
  StephenMcdonald Speaker Australia
• Q&A

• Linking renal pathology to kidney function
• Current Perspectives on the Management of C3 Glomerulopathy: From Diagnosis to Targeted Therapy
  ShoichiMaruyama Speaker Japan
• Update on the Cardio-Kidney Metabolic Syndrome
  SolaAoun Bahous Speaker Lebanon

• Kidneys/bladder – diagnostic US
  ToshihideNaganuma Speaker Japan

  VandanaNiyyar Speaker United States
• Kidney biopsy
  BernardoMoguel González Speaker Mexico

  Hoon SukPark Speaker South Korea
• Volume assessment: Cardiac/VeXus
  BhavnaBhasin-Chhabra Speaker United States

  EduardoArgaiz Speaker Mexico

• Addressing Kidney Disease in Japan: How Does the National Policy Meet Global Commitments
  YosukeYamada Speaker Japan
• Transforming Kidney Care Through National Strategy: A Nephrologist Perspective
  NaokiKashihara Speaker Japan
• Living the Strategy: A Patient’s Perspective on Navigating Kidney Care in Japan
  TakeshiShukunobe Speaker Japan
• Financing Kidney Health: Sustainable and Innovative National Approaches
  YusukeSuzuki Speaker Japan

• Case Discussion 1
• Case Discussion 2
• Case Discussion 3
  SuchinWorawichawong Speaker Thailand
• Case Discussion 4
  Mineaki Kitamura Speaker Japan

• Managing the metabolic complications of kidney failure in Conservative Kidney Management
  SaraDavison Speaker Canada
• Transitioning near the end of life – care of the dying Conservative Kidney Management patient including symptomatology in this period
  NandiniVallath Speaker India

• Practical aspects of implementation science; hands-on studies
  Tae WonYi Speaker Canada
• Value of implementation science
  RukshanaShroff Speaker United Kingdom
• Implementation Science in Digital Health: Clinical Trials Using Mobile Applications for Patient Interventions
  YusukeSakaguchi Speaker Japan
• Take Home Messages
  MegJardine Speaker Australia

• Onco-nephrology in the kidney transplant population
  RobertCarroll Speaker Australia
• Oncohypertension
  SabineKaram Speaker United States
• GFR estimation in the cancer patient
  ShuchiAnand Speaker United States
• Q&A and Final Remarks
  KenarJhaveri Moderator United States

• Why we need standardised data in CKD registries
  AlejandroFerreiro-Fuentes Speaker Uruguay
• Experience from the UK in harmonizing routine CKD data for research
  SamiraBell Speaker United Kingdom
• Challenges for harmonising CKD data at a global level
  JamesWetmore Speaker United States
• Q&A

• Integrating Kidney Health into NCD Strategies: A Regional Perspective from WHO
  HuongTran Speaker Vietnam
• Data‑Driven Kidney Health in Taiwan
  Mai SzuWu Speaker Taiwan
• Advancing Kidney Disease Prevention and Care in China
  LuxiaZhang Speaker China
• Addressing Kidney Disease through the National Health Plan 2030 in the Republic of Korea
  Kook-HwanOh Speaker Korea (Republic of)
• Bridging the Gap Between Policy and Patient Reality
  ManvirVictor Speaker Malaysia
• Panel Discussion

• How do I manage: the hepatorenal syndrome
  Lori-AnnFisher Speaker Jamaica
• How do I manage: checkpoint inhibitor-associated AKI
  MitchellRosner Speaker United States

• Introduction
  BernardoMoguel González Speaker Mexico

• The Gut as a Central Hub of Inter-Organ Cross-Talk in Chronic Kidney Disease
  LaetitiaKoppe Speaker France
• Deciphering Gut Dysbiosis: Is It Age or Kidney Disease?
  JohannesHolle Speaker Germany
• Inflammation Under Neural Control: The Gut-Brain-Kidney Triad in Acute Kidney Injury
  MarkOkusa Speaker United States
• Q&A

• The genetics of nephrotic syndrome/FSGS
  DanielGale Speaker United Kingdom
• The immunology of nephrotic syndrome/FSGS

• Deep Learning in CKD Risk Stratification
• AI-Driven Predictive Models for Acute Kidney Injury (AKI) and Critical Care Nephrology
• AI-enhanced Analysis of Kidney Biopsies
  IsaoMatsui Speaker Japan
• Q&A

• What is a Non-physician Healthcare Model and What Are the Steps to Develop One in CKD Care?
  Carmen ElenaCervantes Speaker United States
• Empowering Primary-level Healthcare Providers Through Targeted Kidney Health Education: Design and Early Experience in India
  PritiMeena Speaker India
• Exploratory Survey for Non-physician Healthcare Workers on Early Detection Resources, Practice, Knowledge, Attitude and Perception Towards CKD: Preliminary Results
  Ana CatalinaAlvarez Elias Speaker United States
• Opportunity to Utilise Non-Physician Healthcare Workers in CKD Care in Fiji
  Yogeshni Chandra Speaker Fiji
• Building Community Kidney Care in Nigeria Through Non-physician Healthcare Workers
  ChimezieOkwuonu Speaker Nigeria
• Curated Discussion

• Gender Disparities in CKD and Dialysis
  MalaSachdeva Speaker United States
• Trials and Tribulations
  KhalidaBulhan - Soki Speaker Kenya
• Improving Randomized Controlled Trials: The Impact of Sex and Gender Reporting and Barriers to Inclusion
  PriyamvadaP S Speaker India
• Q&A

• The latest evidence on the environmental impact of kidney care
  VivekanandJha Speaker India
• The GREEN-K toolkit in practice
  Winston Wing ShingFung Speaker Hong Kong, China
• Greening nephrology in LMIC settings

• Novel Treatment in septic-AKI
  Kent Doi Speaker Japan
• Innovation in promoting Kidney Recovery After Acute Kidney Injury
  MarliesOstermann Speaker United Kingdom
• Global Burden of AKI: Challenges and Barriers
  NattachaiSrisawat Speaker Thailand
• Neonatal Acute Kidney Injury: Long-term Consequences
• Q&A

• The Evolving Biology of CKD-MBD: Implications for Clinical Care
  MarcVervloet Speaker Netherlands
• Updates on CKD-MBD management: conclusions from KDIGO Controversies Conference
• Growing Up With Chronic Kidney Disease-Mineral and Bone Disorder: Pediatric Challenges
  RukshanaShroff Speaker United Kingdom

• Remodel Overview - Framework And Key Outcomes
  PetterBjornstad Speaker United States
• Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial
  DavidCherney Speaker Canada
• ACHIEVE
• Prepare For Kidney Care: Preparing For Responsive Management Versus Preparing For Renal Dialysis In Multimorbid Frail Older People With Chronic Kidney Disease
  FergusCaskey Speaker United Kingdom
• B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil
  JulienHogan Speaker France

• Tracking the Evolution of Kidney Health Systems: Insights from ISN-GKHA 2017–2024
  GeorginaIrish Speaker Australia
• From Data to Action: How the ISN-GKHA Map Drives Policy and Advocacy
  MarinaWainstein Speaker Argentina
• Looking Ahead: Priorities and Plans for the ISN-GKHA 2027 Edition

• New Rules: Updated BP Guidelines From Around the World
  TaraChang Speaker United States
• New Tools: What Nephrologists Need to Know About Novel Antihypertensive Treatments
  Seung HyeokHan Speaker South Korea
• New Paths: Implementation of the Global Hearts Program to Improve Population BP Control
  SwapnilHiremath Speaker Canada
• Optimizing Hypertension Management Across the Lifespan
  Magdalena Madero Speaker Mexico
• Q&A

• IgA Nephropathy Study: Current and Perspective
  XueqingYu Speaker China
• Optimizing Management of Lupus Nephritis – The Clinical, The Bytes and The Bench
  DesmondYap Speaker Hong Kong, China
• Seeds of Change: Growing Together – The Collaborative Journey of APSN-YNC
  KornchanokVareesangthip Speaker Thailand
• Genetics of Chronic Kidney Disease in East Asians
  YukaSugawara Speaker Japan

• Pathomic-driven Tissue Interrogation: Harnessing Collaborative Intelligence and Data Integration for Diagnostic Innovation
  LauraBarisoni Speaker United States
• Multiscalar Data Integration Tools to Redefine Kidney Disease in Mechanistic Terms
  NilsGehlenborg Speaker United States
• Introduction Into the Training Session: Exploring Single Cell and Spatial Data Sets in the KPMP Atlas and Human Cell X Gene Tools
  NikkiBonevich Speaker United States
• Training Session Introduction: Nephroseq and TranSMART for Global Kidney Data Mining
  HeatherAscani Speaker United States
• Q&A

• AKI and AKD definitions and prognosis: What's New in the Updated Guideline?
  SamiraBell Speaker United Kingdom
• Identification and Prevention of AKI/AKD in High-risk Scenarios
  MarliesOstermann Speaker United Kingdom
• Management of AKI/AKD in Clinical Scenarios
  KathleenLui Speaker United States
• Optimizing Kidney Replacement Therapy in Acute Kidney Injury and Acute Kidney Disease
  NattachaiSrisawat Speaker Thailand
• Q&A

• A Role for Kidney Resident B/plasma Cells in Kidney Disease Progression?
  HeatherReich Speaker Canada
• The Role of BAFF and APRIL in Glomerular Disease
  HongZhang Speaker China
• B Cell Targeted Therapies in Glomerular Diseases
  RichardLafayette Speaker United States
• The Future of B Cell Therapies in the Treatment of Glomerular Diseases
  Jonathan Barratt Speaker United Kingdom

• ASPIRE (Aspirin in Dialysis PTS/ China): Large Pragmatic Trial
  XueqingYu Speaker China
• RESOLVE  (NA CONCENTRTION IN DIALYSIS POPULATIONS: GLOBAL): CLUSTER RANDOMIZED TRIAL
  MegJardine Speaker Australia
• VOICE
• TEST PD
  JosephineChow Speaker Australia
• Renal Life Cycle
  HiddoLambers Heerspink Speaker Netherlands
• Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far
  Selvin Sundar RajMani Speaker India

• Micro Scenario 1 Water disruption: 2050 simulation vignette
  SayakaIshigaki Speaker Japan
• Micro-Scenario 2: Digital outage and logistics delay
  Chia-TerChao Speaker Taiwan

• Peritoneal Dialysis as an Implementation Problem - the Role of the International Home Dialysis Consortium
  SimonDavies Speaker United Kingdom
• Home Dialysis: Is It Better for Patient Outcomes?
  ChristopherChan Speaker Canada
• Beyond Traditional Boundaries: Wearable Artificial Kidneys and Portable Dialysis Technologies
  MarjorieFoo Speaker Singapore
• Q&A

• Introduction of Kaplan & Award Presentation
  VicenteTorres Chair United States
• TBA
  RonaldGansevoort Speaker Netherlands
• Platform trials in PKD: Opportunities and Challenges
  MegJardine Speaker Australia
• Is there a role for SGLT2 inhibitors and GLP analogues in treating PKD
  MichelChonchol Speaker United States

• My Kidneys and Me: A Digital Platform for Empowering CKD Self-Management
• Community-Driven Innovation: Redesigning CKD Care in Ghana’s Health System
• Community-Based CKD Screening and Management: A Thai Primary Care Model
  TalerngsakKanjanabuch Speaker Thailand
• Group-based Care Models for Chronic Kidney Disease: A Latin American Perspective
  PaulaMarioli Speaker Argentina

• Key Takeaways from the 2026 WKD Editorial: Shaping the Future of Kidney Health
  DinaAbdellatif Speaker Egypt
• Kidney Health and Planetary Health: Recent Insights into their Intricate Relationship
  GopalakrishnanNatarajan Speaker India
• The Power of the Patient Voice: Driving Change in Healthcare and Research
  NicoleScholes-Robertson Speaker Australia
• Driving Change in Kidney Care: Lessons and Tools That Work
  Augusto CesarSoares dos Santos Junior Speaker Brazil
• Q&A

• Modern Management of Diabetic Kidney Disease: From Early Detection to Precision Therapy
  JanakaKaralliedde Speaker United Kingdom
• Beyond HbA1c: Using CGM to Guide Therapy in Patients with Kidney Disease
  JuliaMader Speaker Austria
• Drug Development in Diabetic Kidney Disease
  PeterRossing Speaker Denmark

• C3G
  HernánTrimarchi Speaker Argentina
• aHUS
  DavidKavanagh Speaker United Kingdom
• Lupus
  LizLightstone Speaker United Kingdom
• IgAN
  HeatherReich Speaker Canada
• Q&A

• EFFICACY AND SAFETY RESULTS OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY ON SODIUM‚ÄÌGLUCOSE CO-TRANSPORTER 2 INHIBITORS: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL (ASSIST)
  HiddoLambers Heerspink Speaker Netherlands
• EFFICACY AND SAFETY OF A TARGETED-RELEASE FORMULATION OF BUDESONIDE (HR19042 CAPSULES) IN PATIENTS WITH PRIMARY IGA NEPHROPATHY: A RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 2/3 TRIAL
  XiaobingYang Speaker China
• EVALUATING THE EFFECT OF SPARSENTAN VS IRBESARTAN ON URINE INFLAMMATORY AND PROFIBROTIC BIOMARKERS IN THE PHASE 3 PROTECT TRIAL OF PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY
• EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN): FINAL 24-MONTH RESULTS FROM THE PHASE III APPLAUSE-IGAN STUDY
  VladoPerkovic Speaker Australia

• Advancing the next wave of therapies in chronic kidney disease
• Effects of finerenone on biomarkers: Mechanistic insights from proteomic analyses in clinical trials
  MarioBerger Speaker Germany
• Future Directions in CRM Care: Advancing Research and Therapeutic Innovation
  AntonioGarreta Rufas Speaker Germany
• Innovative strategies for clinical trial design in IgAN
• Improving outcomes in complement-mediated kidney diseases
  Marianne Silkjær Nielsen Speaker Switzerland
• Advancing Mechanistic Trials through Industry–Academia Collaboration: Insights from the REMODEL Trial
  ManuelMayrdorfer Speaker Denmark
• Why? When? How? How to maximize patient outcomes from the start of dialysis
  PeterRutherford Speaker Switzerland

• Return to Country; Evaluating Health Service Bias and the Impact of Place Based Cultural Safety Initiatives (co-presentation)
  KelliOwen Speaker Australia

  ScottJones Speaker Australia
• Equity in Action: Improving Access to Kidney Transplantation Through Community Partnerships in Rural, Remote, and Indigenous Communities
  AnuragSingh Speaker Canada
• Celebrating Cultural Inclusion and Safety in Academia and Medical Education
  LukeWilson Speaker New Zealand
• Q&A

• Autoantibodies targeting podocyte-specific antigens in primary nephrotic syndrome
• Insights from the Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) groups
  AlessiaFornoni Speaker United States
• Podocyte directed progression of kidney injury in FGS and DKD
  John CijiangHe Speaker United States

• Opening & Session Overview
  AdeeraLevin Speaker Canada
• Overcoming the Bottleneck- Endpoints in Phase 2 Trials
  Kai-UweEckardt Speaker Germany
• Integrating Patient-Reported Outcomes (PROMs)
  AllisonJaure Speaker Australia
• Innovating with New Trial Designs
  MegJardine Speaker Australia
• Using Hierarchical Composite Endpoints (HCEs)
  HiddoLambers Heerspink Speaker Netherlands
• Panel Discussion & Q&A
• Closing Remarks
  MasaomiNangaku Speaker Japan

• Building Trust and Hope in End-Stage Kidney Disease Care
  NoriakiKurita Speaker Japan
• The Role of Advance Care Planning in Supporting Decision-making About Kidney Care
  KathrynDucharlet Speaker Australia
• Patient Involvement in Shaping End-of-Life Kidney Care Policies
  ManvirVictor Speaker Malaysia
• Q&A

• What Will Be the Future of Personalised Immunosuppression in Children?
  LarsPape Speaker Germany
• Can We Prevent Fsgs From Recurring in Children?
  PriyaVerghese Speaker United States
• What Is the Role of Anti-Nephrin Antibody in Pediatric Kidney Transplantation?
  YukoHamasaki Speaker Japan
• Q&A

• Complement inhibition should be considered before nefecon in patients with IgAN at risk of progression
• Nefecon should be considered before complement inhibition in patients with IgAN at risk of progression

• Setting the Scene (vision and scope)
  PierreRonco Speaker France
• Introducing KICR Journal
  SwapnilHiremath Speaker Canada
• Choosing the right nephrology journal
  PierreRonco Speaker France
• How Editors assess the manuscript
  BradRovin Speaker United States
• Responding to Reviewer's comments
  JaiRadhakrishnan Speaker United States
• Dealing with the Stats?
  GermaineWong Speaker Australia
• From first draft to first author in KI - Perspectives of an Editorial Fellow
  GriffithPerkins Speaker Australia
• Panel Discussion

• Shaping the Future of Kidney Regeneration
  TakashiYokoo Speaker Japan
• State-of-the-Art Approaches in Kidney Regenerative Science
• From iPS Cells to Kidneys: A Roadmap to Regeneration
  KenjiOsafune Speaker Japan
• Breakthrough Discoveries Shaping the Future of Kidney Repair
  YunXia Speaker Singapore
• Q&A

• Adeno-associated Viral Therapy in Kidney Diseases
  HiroyukiNakai Speaker United States
• CAR-T Cell Therapy in Lupus
  BradRovin Speaker United States
• CAR-T Therapy in Kidney Transplantation
  TambiJarmi Speaker United States
• TBC
• Q&A

• Abstract winner TBD: highlighting young talent, providing opportunity to present
• Abstract winner TBD: highlighting young talent, providing opportunity to present
• Molecular Mechanisms of Kidney Aging: From Bench to Bedside
  TakeshiYamamoto Speaker Japan
• Frailty Frameworks: Guideline‑Driven Care
  HannahBeckwith Speaker United Kingdom
• Providing Care for the Aging Kidney in Low-resource Settings
  AhadQayyum Speaker Pakistan
• Synergy in Senescence: A Young at Heart Panel
  TakeshiYamamoto Speaker Japan

• Kidney International in Focus: Annual Highlights
  PierreRonco Speaker France
• ISN-KI Fellows: Showcasing Excellence Part 1: Pediatrics
  GabrielCara-Fuentes Speaker United States
• ISN-KI Fellows: Showcasing Excellence Part 2: Clinical Nephrology
  SaharKoubar Speaker United States
• ISN-KI Fellows: Showcasing Excellence Part 3: Epidemiology & Clinical Trials
  DavidTunnicliffe Speaker Australia
• ISN-KI Fellows: Showcasing Excellence Part 4: Basic & Translational Science
  NahidTabibzadeh Speaker France
• Kidney International Reports in Focus: Annual Highlights
  JaiRadhakrishnan Speaker United States
• Kidney International Reports in Focus: Annual Highlights
  SumitMohan Speaker United States
• Kidney International Reports in Focus: Annual Highlights
  SumitMohan Speaker United States
• Celebrating Excellence: Best Reviewer Awards Presentation
  BradRovin Speaker United States
• Presentation of Basic Science Awards (Early Career Researcher Awards)
  BERNHARDDUMOULIN Speaker United States
• Presentation of Clinical Science Awards (Early Career Researcher Awards)
  Joint Presentations
  EmilyBowen Speaker United Kingdom

  Louis-CharlesDesbiens Speaker Canada
• ISN-KI fellows: What have they become?
  GermaineWong Speaker Australia

• Is Kidney Dysfunction in Heart Failure More Than Just Low Cardiac Output?
  BrendonNeuen Speaker Australia
• Is Metabolic Dysfunction in Cardiovascular-Kidney-Metabolic Syndrome More Than Just Hyperglycemia and Obesity?
  HiddoLambers Heerspink Speaker Netherlands
• Kidney at the Center of Conservative Kidney Management Syndrome
  MasaomiNangaku Speaker Japan
• What’s Next in Cardiovascular-Kidney-Metabolic Therapy?
  RobertoPecoits-Filho Speaker United States
• Q&A

• Complement and Genetic Complementopathies
  AnujaJava Speaker United States
• Precision Medicine in Glomerular Disease
  JonathanHimmelfarb Speaker United States
• Complement and IgA Nephropathy
  AdrianLiew Speaker Singapore
• Complement and Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis
• Q&A

• EFFECT OF A 12-WEEK INTRADIALYTIC CYCLING INTERVENTION ON HEMODIALYSIS-INDUCED MYOCARDIAL STUNNING: A MULTI-CENTRE RANDOMIZED CONTROLLED TRIAL (TICKERS_HD)
  ClaraBohm Speaker Canada
• EFFECT OF FINERENONE ON CIRCULATING BIOMARKERS: A CONFIDENCE ANALYSIS
  MarioBerger Speaker Germany
• EFFECT OF SIMULTANEOUS INITIATION OF FINERENONE AND EMPAGLIFLOZIN ON URINARY ALBUMIN-TO-CREATININE RATIO BY AGE AND SEX IN THE CONFIDENCE TRIAL
  RajivAgarwal Speaker United States
• A CONTROLLED, RANDOMIZED CLINICAL TRIAL OF PERSONALIZED TWO-PHASE REGIONAL CITRATE ANTICOAGULATION IN PROLONGED INTERMITTENT KIDNEY REPLACEMENT THERAPY
  QiZhang Speaker China
• LOWERING-HYPERURICEMIA TREATMENT ON CARDIOVASCULAR OUTCOMES IN PERITONEAL DIALYSIS PATIENTS: A PROSPECTIVE, MULTICENTER, DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL
  Naya Huang Speaker China

• Understanding the CKDu Challenge: A Global Health Priority
  ErangaWijewickrama Speaker Sri Lanka
• Inside the ISN i3C CKDu Toolkit: Structure, Stages, and Key Components
  Ana CatalinaAlvarez Elias Speaker United States
• From Knowledge to Action: Implementing the Toolkit for Global Impact

• Cancer Screening in Kidney Transplant Recipients and Patients on Dialysis
  Chi Yuen SimonCheung Speaker Hong Kong, China
• Chronic Kidney Disease After Childhood Cancer
  Maria JoseSoler Speaker Spain
• Palliative Care in Cancer Patients With Kidney Disease: The Nephrologist's Role
• Q&A

• ISN Train-the-Trainer Program Overview
  ShilpanjaliJesudason Speaker Australia
• Rapid Fire update 1
• Rapid Fire Update 2
• Q&A

• Introduction
• YNN promotion
• Hot Debate: Xenotransplants and Stem Cells can Replace Human Organ Donations - PRO
  I-RuChen Speaker Taiwan
• Hot Debate: Xenotransplants and Stem Cells can Replace Human Organ Donations - CON
  UgochiOnu Speaker Nigeria
• Hot Debate: Xenotransplants and Stem Cells can Replace Human Organ Donations - PRO
  Milagros MelissaFlores Fonseca Speaker Mexico
• Hot Debate: Xenotransplants and Stem Cells can Replace Human Organ Donations - CON
  HirakuTsujimoto Speaker Japan
• Q&A: Expert Dialogue on [Session Topic]
  KenjiMatsui Judge United States

  NihalBashir Judge United Arab Emirates
• Voting and Summary
• Announce Winners and Prize Presentation

• Structure and Function of the Feline Kidney: Clinical Perspectives on Disease Development
  TakakoShimokawa Speaker Japan
• TBC
• Physiological functions of a cetacean-specific aquaporin
  MiwaSuzuki Speaker Japan
• Q&A

• Implementing the WHO Resolution on Kidney Health
  MarcelloTonelli Speaker Canada

• Supporting Patients in Choosing Peritoneal Dialysis as a Treatment Option
  RajnishMehrotra Speaker United States
• Person-centered multidimensional support for patients on home dialysis
  RachaelWalker Speaker New Zealand
• Peritoneal Dialysis for Older Adults With Kidney Failure
  EdwinaBrown Speaker United Kingdom
• Hybrid PD and HD: Solution for long-term patients?
  YasuhikoIto Speaker Japan
• Q&A

• Existing and Emerging Challenges to Providing Equitable and Sustainable Kidney Care
  AndrejSkoberne Speaker Slovenia
• Biological and Clinical Sex Differences in Kidney Health and Disease
  KateStevens Speaker United Kingdom
• Opportunities for Delivering Equitable and Sustainable Kidney Care
  LuxiaZhang Speaker China
• Q&A

• Paediatric Transplantation in LMICs: Building Family-Centered Infrastructure
  PriyaPais Speaker India
• Against the Odds: Establishing a Hospital-Based Transplant Program in Cameroon
  GloriaAshuntantang Speaker Cameroon
• Collaboration and Commitment: Malaysia's Journey Toward Transplant Independence
  Muhammad IqbalAbdul Hafidz Speaker Malaysia
• Q&A

• Opening & Session Introduction
  AdeeraLevin Chair Canada
• Global Overview: The ISN-Global Kidney Health Atlas 2025 Update
  SomkanyaTungsanga Speaker Canada
• Regional Perspectives: Gaps and Successes in Kidney Care Delivery
  ArpanaIyengar Speaker India
• Innovation & Collaboration for Better Kidney Health
  AminuBello Speaker Canada
• Future Directions Q&A & Closing
  MasaomiNangaku Speaker Japan

• Recent Advances in Treatment of Pediatric Nephrotic Syndrome
  KoichiNAKANISHI Speaker Japan
• TBA
  RulanParekh Speaker Canada
• Anti-CD20 Monoclonal Antibodies in Childhood Nephrotic Syndrome: Evolving Therapeutic Landscape
  Eugene Yu HinChan Speaker Hong Kong, China

• Anti-nephrin mediated podocytopathy
  Felicitas E.Hengel Speaker Germany
• PLA2R epitope pairing is essential for complement activation in membranous nephropathy
  Cheng-LungKu Speaker Taiwan
• Novel Anti-GBM antibodies
  Ming-huiZhao Speaker China

• Mandatory reporting of suspicious cases
  Maria AmaliaMatamoros Speaker Costa Rica
• Incentives to Reduce Organ Shortage
  KhalidaBulhan - Soki Speaker Kenya
• Addressing Inequities to Prevent Organ Trafficking and Transplant Tourism
  LiliaCervantes Speaker United States
• Q&A

• Patient-reported Outcomes in Glomerular Disease: Considering the Whole Person
  MichelleO'Shaughnessy Speaker Ireland
• Infectious Complications in Primary Glomerular Disease: Ensuring the Cure Isn’t Worse Than the Disease
  BalazsOdler Speaker Austria
• Cardiovascular Disease in Primary Glomerular Diseases: Quantifying and Reducing Risk
  MarkCanney Speaker Canada
• Q&A

• Introduction to Implementation Science in AKI and Acute Care Nephrology
  YuvaramReddy Speaker United States
• What Is the Acute Disease Quality Initiative (ADQI) and Why Do We Need ADQI XXXV?
  MarliesOstermann Speaker United Kingdom
• What Did We Learn in ADQI XXXV?
  OleksaRewa Speaker Canada
• Q&A

• KDIGO Updates on Management of CKD Anemia
• Global Disparities in CKD Anemia Management
  SunitaBavanandan Speaker Malaysia
• Beyond Erythropoiesis-stimulating Agents and Iron: Navigating the Future of Anemia of Chronic Kidney Disease Management
  Kai-UweEckardt Speaker Germany
• Q&A

• Advancing Clinical Trials: Empowering the Kidney Community Through Clinical Trial Awareness
  AndreaViecelli Speaker Australia
• The ISN TrialWatch: Bringing the Latest Evidence to the Kidney Community
  MeganBorkum Speaker Canada
• The ISN Guide for Everyone: Making Clinical Research Accessible and Meaningful
  AdeeraLevin Speaker Canada

• Global Burden of Pregnancy Associated Acute Kidney Injury - Presentation of the Global 2025 Survey and Snapshot Study
  RashaShemies Speaker Egypt
• Improving Diagnosis of Kidney Disease in Pregnancy - New Definitions for All Resource Settings Including Pregnancy TMA
  KatherineClark Speaker United Kingdom
• CKD in Pregnancy - New Approaches to a Growing Challenge
  DIVYABAJPAI Speaker India
• Implementing Simple, Scalable, Co-designed Solutions for Kidney Health in Policy and Practice
  StephenMutiso Speaker Kenya
• Q&A

• Understanding Gender Disparities in Kidney Transplantation - a Causal Inference Approach
  JessicaHarding Speaker United States
• Pragmatic Medicine - Learning From the Indian Experience
  Shyam BihariBansal Speaker India
• Strategies to Help Patients With Medications and Complex Medical Systems
• Reducing the Environmental Footprint in Transplantation
  IvoLaranjinha Speaker Portugal
• Q&A

• Pre-test: Deep Dive Into the Indication of Genetic Testing, is the More the Merrier?
  RoserTorra Speaker Spain
• The Test: Nephro-genomic Board Simulation: Variant Scientist X Genetic Nephrologist
  DanielGale Speaker United Kingdom
• Risk Alleles and Low Penetrance Variants in Nephrology: The Gap in Evidence
  JanewitWongboonsin Speaker Thailand
• The Patient Voice
  SusieGear Speaker United Kingdom

• Dialysis Membrane and Survival
  AbeMasanori Speaker Japan
• Sex Differences and Prognosis in Dialysis Patients
  SaoriNishio Speaker Japan
• Practical aspects of preserving PD membrane
  Ana Elizabeth Figueiredo Speaker Brazil

• Climate, Country, and Kidney Health: Indigenous Perspectives on Environmental and Health Justice
• Green Nephrology: Rethinking Sustainability in Dialysis Systems
  Winston Wing ShingFung Speaker Hong Kong, China
• Heat, Sweat, and Silence: Two Decades of Uncovering Mesoamerican Nephropathy
  RamonGarcia Trabanino Speaker El Salvador
• When Funding Fades: Geopolitical Shifts and Kidney Health in Fragile Settings
  GraceKansiime Speaker Uganda
• Q&A

• Complement activation in Diabetic Kidney Disease
  MinChen Speaker China
• Spatial Transcriptomics in Diabetic Kidney Disease
  BERNHARDDUMOULIN Speaker United States
• Metabolomics in Diabetic Kidney Disease
  ReikoInagi Speaker Japan

• ISN Roles in Humanitarian Works
  AliAbu-Alfa Speaker Lebanon
• Preparedness for a Disaster: Pitfalls and Solutions
  SerhanTuglular Speaker Turkey
• Earthquake Disaster: Lessons Learnt from Japan
  KeiFukami Speaker Japan
• Resilient Kidney Care: Adaptation and Recovery After a Disaster
  SabineKaram Speaker United States
• Q&A